Compile Data Set for Download or QSAR
maximum 50k data
Found 30 Enz. Inhib. hit(s) with all data for entry = 10626
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555274(34(2,6-dichloro-1-(1-propyl-1H-pyrazol-4-yl)-1H-in...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555302(2-(3-(((6-chloro-2-cyclopropyl-7-fluoro-1-(1-ethyl...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555276(34(6-chloro-2-cyano-1-(1-propyl-1H-pyrazol-4-yl)-1...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555277(3-((6-chloro-2-cyclopropyl-1-(1-propyl-1H-pyrazol-...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555278(34(2,6-dichloro-7-fluoro-1-(1-propyl-1H-pyrazol-4-...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555279(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-propyl-1H...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555280(3-((2,6-dichloro-7-fluoro-1-(1-propyl-1H-pyrazol-4...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555281(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-propyl-1H...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555282(3-((2,6-dichloro-1-(1-ethyl-1H-pyrazol-4-yl)-7-flu...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(34(6-chloro-2-cyclopropyl-1-(1-(ethyl-d5)-1H-pyraz...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555284(3-((2,6-dichloro-7-fluoro-1-(1-methyl-1H-pyrazol-4...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555285(6-((6-chloro-2-cyclopropyl-1-(1-ethyl-1H-pyrazol-4...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555286(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1H-pyrazol-...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555287(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-(2-hydrox...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555288(34(1-(1-(2-(carbamoyloxy)ethyl)-1H-pyrazol-4-yl)-6...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555289(3-((1-(1-(2-aminoethyl)-1H-pyrazol-4-yl)-6-chloro-...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555290(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-(2-ureido...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555291(34(1-(1-(3-carboxypropyl)-1H-pyrazol-4-yl)-6-chlor...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555292(34(1-(1-(4-amino-4-oxobutyl)-1H-pyrazol-4-yl)-6-ch...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555293(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-(2,2,2-tr...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(34(6-chloro-2-cyclopropyl-1-(1-(ethyl-d5)-1H-pyraz...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555294(34(6-chloro-2-cyclopropyl-1-(1-(ethyl-d5)-1H-pyraz...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555295(3-((1-(1-(6-aminoethyl)-1H-pyrazol-4-yl)-6-chloro-...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555296(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(1-(hex-5-yn...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555297(3-((1-(1-(3-hydroxy-2,2-dimethylpropyl)-1H-pyrazol...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555298(3-(((6-chloro-2-cyclopropyl-1-(1-(6-(3-(3′,6...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555299(34(2,6-dichloro-7-fluoro-1-(pyridin-3-yl)-1H-indol...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555300(34(2-bromo-6-chloro-7-fluoro-1-(pyridin-3-yl)-1H-i...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555301(3-((6-chloro-2-cyclopropyl-7-fluoro-1-(pyridin-3-y...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetEctonucleotide pyrophosphatase/phosphodiesterase family member 2(Homo sapiens (Human))
Sabre Therapeutics

US Patent
LigandPNGBDBM555275(34(2-bromo-6-chloro-1-(1-propyl-1H-pyrazol-4-yl)-1...)
Affinity DataIC50: <500nMAssay Description:ATX activity is assayed in concentrated conditioned media from Hep3B human hepatocellular carcinoma cells by measuring the amount of choline released...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent